v3.26.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Balance at Dec. 31, 2024 $ 754,903 $ 1,456,836 $ 199,149 $ (899,470) $ (1,612)
Balance (in Shares) at Dec. 31, 2024   76,416,086      
Net loss for the period (65,047)     (65,047)  
Stock-based compensation expense 12,174   12,174    
Issuance of common shares pursuant to equity incentive plans 1,151 $ 4,014 (2,863)    
Issuance of common shares pursuant to equity incentive plans (in shares)   170,273      
Other comprehensive income (loss) 776       776
Balance at Mar. 31, 2025 703,957 $ 1,460,850 208,460 (964,517) (836)
Balance (in Shares) at Mar. 31, 2025   76,586,359      
Balance at Dec. 31, 2024 754,903 $ 1,456,836 199,149 (899,470) (1,612)
Balance (in Shares) at Dec. 31, 2024   76,416,086      
Net loss for the period (149,753)        
Balance at Jun. 30, 2025 633,978 $ 1,469,196 213,892 (1,049,223) 113
Balance (in Shares) at Jun. 30, 2025   76,939,811      
Balance at Mar. 31, 2025 703,957 $ 1,460,850 208,460 (964,517) (836)
Balance (in Shares) at Mar. 31, 2025   76,586,359      
Net loss for the period (84,706)     (84,706)  
Stock-based compensation expense 13,713   13,713    
Issuance of common shares pursuant to equity incentive plans 65 $ 8,346 (8,281)    
Issuance of common shares pursuant to equity incentive plans (in shares)   353,452      
Other comprehensive income (loss) 949       949
Balance at Jun. 30, 2025 633,978 $ 1,469,196 213,892 (1,049,223) 113
Balance (in Shares) at Jun. 30, 2025   76,939,811      
Balance at Dec. 31, 2025 581,760 $ 1,598,571 228,234 (1,245,380) 335
Balance (in Shares) at Dec. 31, 2025   80,010,790      
Net loss for the period (102,302)     (102,302)  
Stock-based compensation expense 16,894   16,894    
Issuance of common shares and pre-funded warrants, net 837,526 $ 790,198 47,328    
Issuance of common shares and pre-funded warrants, net   15,370,962      
Exercise of pre-funded warrants (in shares)   118,980      
Exercise of pre-funded warrants   $ 3,296 (3,296)    
Issuance of common shares pursuant to equity incentive plans 5,487 $ 29,768 (24,281)    
Issuance of common shares pursuant to equity incentive plans (in shares)   1,123,391      
Other comprehensive income (loss) (1,546)       (1,546)
Balance at Mar. 31, 2026 1,337,819 $ 2,421,833 264,879 (1,347,682) (1,211)
Balance (in Shares) at Mar. 31, 2026   96,624,123      
Balance at Dec. 31, 2025 581,760 $ 1,598,571 228,234 (1,245,380) 335
Balance (in Shares) at Dec. 31, 2025   80,010,790      
Net loss for the period (213,038)        
Balance at Jun. 30, 2026 1,242,396 $ 2,426,619 276,851 (1,458,418) (2,656)
Balance (in Shares) at Jun. 30, 2026   96,752,884      
Balance at Mar. 31, 2026 1,337,819 $ 2,421,833 264,879 (1,347,682) (1,211)
Balance (in Shares) at Mar. 31, 2026   96,624,123      
Net loss for the period (110,736)     (110,736)  
Stock-based compensation expense 16,732   16,732    
Issuance of common shares pursuant to equity incentive plans 26 $ 4,786 (4,760)    
Issuance of common shares pursuant to equity incentive plans (in shares)   128,761      
Other comprehensive income (loss) (1,445)       (1,445)
Balance at Jun. 30, 2026 $ 1,242,396 $ 2,426,619 $ 276,851 $ (1,458,418) $ (2,656)
Balance (in Shares) at Jun. 30, 2026   96,752,884